. Private consumption and investment tend to increase despite some of them slowdown from the outbreak of Omicron-type COVID-19. Public expenditures expanded comparing to the Q1-2021 due to capital
Company had to resort to very competitive pricing which impacted the EBITDA adversely. On 11 March 2020, the World Health Organization declared the Coronavirus (“COVID-19”) outbreak as a pandemic which
previous projected at 2.8% growth to a 5.3% contraction due to the fact that COVID-19 outbreak severely affected both external and domestic demand particularly the tourism and exporting sector which sharply
infection, easing measures to contain COVID-19 outbreak and lifting domestic travel restrictions in Thailand and several countries recently, various business strategies and marketing plans to be implemented
significant changes in liabilities in the first quarter of 2020, which was an increase in debentures of the subsidiary that raised funds. Issued debentures before the COVID-19 outbreak and lease liabilities
entire 2nd quarter of 2020, sales were seen to be increasing back towards normal levels in late June due to the improvement in the domestic COVID-19 outbreak situation. The Group is confident that further
affected by the COVID–19 outbreak. However, the Company’s revenues generate from large projects that have continued its operation since 2019. Moreover, most of the customers are government agencies and state
restriction to curb the Coronavirus outbreak. The entry plan remains around Bt400. Operators are building in VDO service and other value added service including mobile bundling to gear toward higher ARPU. 2Q21
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as